Page last updated: 2024-10-27

foscarnet and Retrolental Fibroplasia

foscarnet has been researched along with Retrolental Fibroplasia in 1 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Research Excerpts

ExcerptRelevanceReference
"Bilateral recurrence of CMV retinitis occurred on day 89 of life, requiring a second course of intravitreal foscarnet injections and intravenous ganciclovir."1.40Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant. ( Baumal, CR; Tawse, KL, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tawse, KL1
Baumal, CR1

Other Studies

1 other study available for foscarnet and Retrolental Fibroplasia

ArticleYear
Intravitreal foscarnet for recurring CMV retinitis in a congenitally infected premature infant.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2014, Volume: 18, Issue:1

    Topics: Antiviral Agents; Cytomegalovirus Retinitis; Female; Foscarnet; Ganciclovir; Gestational Age; Humans

2014